Altogether, our data suggest a pathogenic role for C99 elevations in AD, via upregulation of cholesterol trafficking and MAM activity, which disrupt cellular lipid homeostasis and cause the alterations in membrane lipid composition commonly observed during AD pathogenesis. This evidence concerns the gene APP and Alzheimer disease.